Williams VS, Smith MY, Fehnel SE. The validity and utility of bpi interference measures addressing the impact of pain. Poster presented at the Annual International Society for Quality of Life Research (ISOQOL) Conference; November 2003.
von Scheele B, DePlatchett J, Gaffney L, Peña BM, Niculescu L. The total costs of treatment with valdecoxib compared to generic diclofenac are similar in patients with rheumatoid arthritis in Germany. Poster presented at the 2003 ISPOR 6th Annual European Congress; November 9, 2003. Barcelona, Spain. [abstract] Value Health. 2003 Nov; 6(6):725-6.
Doward LC, Spoorenberg A, Whalley D, Cook SA, Helliwell PS, Kay LJ, McKenna SP, Tennant A, van der Heijde D, Chamberlain MA. Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis. Ann Rheum Dis. 2003 Jan 1;62(1):20-6.
van der Heijde D, Dougados M, DeMuro-Mercon CJ, Melian A, Watson DJ. Validation of the ankylosing spondylitis quality of life questionnaire (ASQoL). Poster presented at the 67th Annual Scientific Meeting of the American College of Rheumatology; 2003.
Johannes CB, Schneider G, Aygun AC, L'Italien GJ, Viveash D, Wallis WJ. Time to first disease modifying anti-rheumatic drug therapy (DMARD) among rheumatic disease patients in a population based study. Poster presented at the American College of Rheumatology Annual Scientific Meeting; 2003.
Cannuscio CC, Genovese M, DeMuro-Mercon CJ, Cai B, Holmes R, Gottesdiener KM. Markers of cardiovascular risk in patients with rheumatoid arthritis (RA) and osteoarthritis (OA). Poster presented at the 67th Annual Scientific Meeting of the American College of Rheumatology; 2003.